Victoria E Walker-Sperling

发表

Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir

R. Siliciano, J. Siliciano, Wei Li, 2022, Science Translational Medicine.

A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads.

J. Clements, J. Blankson, M. Zink, 2015, The Journal of infectious diseases.

Characterization of the Active Microbiotas Associated with Honey Bees Reveals Healthier and Broader Communities when Colonies are Genetically Diverse

Irene L. G. Newton, G. Roeselers, H. Mattila, 2012, PloS one.

Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques

R. Siliciano, G. Alter, D. Barouch, 2021, Nature Communications.

The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication

J. Blankson, P. Tarwater, C. Pohlmeyer, 2016, EBioMedicine.

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Allan C. deCamp, J. Mascola, R. Koup, 2022, Nature Medicine.

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller

M. Carrington, O. Laeyendecker, J. Blankson, 2017, EBioMedicine.

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells

J. Blankson, P. Tarwater, Valerie J Cohen, 2015, Journal of Virology.

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4 (cid:2) T Cells to HIV-1-Speciﬁc CD8 (cid:2) T Cells

J. Blankson, P. Tarwater, Valerie J Cohen, 2015 .

Comparative Analysis of the Capacity of Elite Suppressor CD4+ and CD8+ T Cells To Inhibit HIV-1 Replication in Monocyte-Derived Macrophages

J. Blankson, R. Buckheit, Victoria E Walker-Sperling, 2014, Journal of Virology.

Monocyte-Derived Macrophages To Inhibit HIV-1 Replication in T Cells + and CD 8 + Elite Suppressor CD 4 Comparative Analysis of the Capacity of

J. Blankson, R. Buckheit, Victoria E Walker-Sperling, 2014 .

What can we do to reduce the viral reservoir in HIV-1-infected individuals?

J. Blankson, C. Pohlmeyer, Victoria E Walker-Sperling, 2016, Future microbiology.

The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells

J. Blankson, L. Gama, L. Pianowski, 2017, PloS one.

Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques

R. Siliciano, H. Schuitemaker, J. Siliciano, 2022, Nature Communications.

Peripheral blood biomarkers predict viral rebound following antiretroviral therapy discontinuation in SIV-infected, early ART-treated rhesus macaques

D. Barouch, Malika Aid, Al Colarusso, 2023, Cell reports. Medicine.

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells

J. Blankson, P. Tarwater, Valerie J Cohen, 2015, Journal of Virology.

Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages.

J. Blankson, C. Merlo, G. Kirk, 2016, AIDS research and human retroviruses.

A Human Immunodeficiency Virus Controller With a Large Population of CD4+CD8+ Double-Positive T Cells

J. Blankson, R. Ambinder, C. Durand, 2015, Open forum infectious diseases.

A Human Immunodeficiency Virus Controller With a Large Population

J. Blankson, R. Ambinder, C. Durand, 2015 .